NYSE$ATR

AptarGroup Inc. · Q1 2025 earnings

Q1 2025 earnings · · After market close · Investor relations

Briefing

AptarGroup reported Q1 2025 net sales of $887.3M with net income of $78.7M and diluted EPS of $1.17.

Net sales were $887.3 million, down modestly from $915.4 million, as pharma and beauty dispensing demand varied by region. Net income was $78.7 million; diluted EPS was $1.17. Operating income was $113.4 million with restructuring initiatives continuing.

  • Q1 net sales $887.3M.
  • Operating income $113.4M; net income $78.7M.
  • Diluted EPS $1.17.
  • Pharma, beauty, and food dispensing segments.
  • Restructuring initiatives of $2.0M in the quarter.

Headline financials

Total Revenue

$887M

Previous: $915M-3.1%
EPS (adj)

$1.17

Previous: $1.23-4.9%
Total Core Sales Growth

0.0%

Previous: 0.0%
Pharma Core Sales Growth

3.0%

Previous: 13.0%-76.9%
Beauty Core Sales Growth

-3.0%

No prior period
Closures Core Sales Growth

-2.0%

No prior period
Capital Expenditures

-$56.9M

Previous: -$75.7M+24.8%
Net Income

$78.8M

Previous: $83.1M-5.2%
Operating Income

$113M

Previous: $112M+1.2%

Revenue & EPS history

AptarGroup · Revenue · Quarterly

$887M

Q1 2025-3.1%vs Q1 2024
Beat estimate in 8 of 15 quarters(53%)
ActualEstimate

Revenue by segment

AptarGroup · $893M total across 3 segments · Q3 2023

  • Pharma
    $389M+13.3%
  • Beauty
    $324M-10.0%
  • Closures
    $180M+34.6%

Forward guidance

Aptar discusses end-market trends in pharma and consumer dispensing; full-year outlook focuses on innovation in sustainable dispensing and emerging market growth.

Tailwinds

  • Pharma and drug-delivery content growth.
  • Sustainability-led product wins.
  • Restructuring savings and margin discipline.

Headwinds

  • Beauty and personal-care destocking.
  • FX headwinds on international sales.
  • Customer inventory normalization timing.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2025

Historical avgQ1 2025

+0.3%

Avg return

Earnings day

-0.1%

Avg return

5 days after

+1.2%

Avg return

30 days after

63%

43 / 68 earnings

Positive

+9.2%

Q4 2017

Best reaction

-9.0%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.3%-0.8%-6.4%
Q4 2025+8.3%+12.9%+6.5%
Q3 2025-9.0%-7.1%+0.3%
Q1 2025+2.3%+2.1%+6.8%
Q4 2024-8.5%-9.4%-2.3%
Q3 2024+0.8%+0.6%+2.3%
Q2 2024+1.7%+1.1%+4.4%
Q1 2024+2.4%+3.1%+5.8%
Q4 2023+5.4%+3.1%+8.6%
Q3 2023+0.1%-0.9%+4.2%
Q2 2023+3.2%+2.1%+6.3%
Q1 2023+2.4%+4.1%-1.4%
Q4 2022+5.7%+4.2%+0.3%
Q3 2022+2.1%-1.9%+6.9%
Q2 2022+1.6%+0.5%-1.5%
Q1 2022+3.4%+2.5%-2.0%
Q4 2021+3.3%+3.8%+2.7%
Q3 2021-3.6%+1.7%+1.0%
Q2 2021-6.3%-6.6%-2.3%
Q1 2021-0.2%+2.6%-2.5%
Q4 2020-7.7%-10.4%-2.7%
Q3 2020+1.6%+6.4%+13.3%
Q2 2020-3.0%-0.2%-0.6%
Q1 2020-3.6%-4.1%+1.2%
Q4 2019-2.6%-7.0%-19.6%
Q3 2019-7.1%-8.9%-6.0%
Q2 2019-5.0%-5.4%-1.3%
Q1 2019+1.3%+2.3%+2.0%
Q4 2018+1.5%+0.0%+2.2%
Q3 2018+1.8%+2.1%+2.0%
Q2 2018+8.6%+8.1%+9.6%
Q1 2018+0.3%+0.4%+1.0%
Q4 2017+9.2%+11.8%+9.6%
Q3 2017-0.6%-1.6%-2.5%
Q2 2017-6.5%-6.3%-6.4%
Q1 2017+1.2%+1.1%+6.3%
Q4 2016+1.7%+0.4%+4.4%
Q3 2016-4.3%-7.4%-0.3%
Q2 2016-1.9%-3.9%-1.6%
Q1 2016-3.1%
Q4 2015-2.8%
Q3 2015+2.4%
Q2 2015+8.3%
Q1 2015+2.4%
Q4 2014+1.8%
Q3 2014+2.0%
Q2 2014-3.5%
Q1 2014-0.1%
Q4 2013+1.9%
Q3 2013+0.2%
Q2 2013-2.1%
Q1 2013-2.0%
Q4 2012-0.8%
Q3 2012-3.5%
Q2 2012+2.6%
Q1 2012+0.9%
Q4 2011+0.1%
Q3 2011+5.8%
Q2 2011-5.0%
Q1 2010+2.2%
Q1 2011+2.3%
Q4 2008+1.5%
Q4 2010+1.5%
Q3 2010+2.9%
Q3 2009+2.9%
Q4 2009+0.5%
Q2 2009+0.5%
Q2 2010+0.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro